Arcus Biosciences, Inc.

NYSE:RCUS

16.49 (USD) • At close September 18, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Omzet 39145313229250.34533.58126.75918.005354.4999.4619.4619.4619.48764.531.751.759.751.751.751.751.5624.2911.251.251.250.16300
Kosten van de omzet 2353443.4293.6093.5293.4332.47371.25468.77166.38748.71251.80135.69323.14220.68617.24124.99915.55411.43612.85913.69911.65212.14621.4357.8345.804
Brutowinst 3714226292521-3.08429.97223.2314.572352.026-61.793-59.31-56.926-39.22512.729-33.943-21.392-10.936-15.491-23.249-13.804-9.874-8.568-12.449-10.402-10.896-21.272-7.834-5.804
Brutowinstmarge 0.9490.9790.8390.9060.8620.84-8.9390.8930.8680.8090.993-6.531-6.269-6.017-4.1350.197-19.396-12.224-1.122-8.852-13.285-7.888-6.321-1.997-9.959-8.322-8.717-130.50300
Onderzoek- en ontwikkelingskosten 115109938284818076.68469.90561.21149.93671.25468.77166.38748.71251.80135.69323.14220.68617.24124.99915.55411.43612.85913.69911.65212.14621.4357.8345.804
Algemene en administratieve kosten 3032293028302826.29425.83623.97423.29616.34316.82615.82112.78711.17711.4327.0086.5917.7585.9114.9693.613.5773.452.9292.4481.8621.831.496
Verkoop- en marketingkosten -200000000000000000000000000000
Verkoop-, algemene en administratieve kosten 2832293028302826.29425.83623.97423.29616.34316.82615.82112.78711.17711.4327.0086.5917.7585.9114.9693.613.5773.452.9292.4481.8621.831.496
Overige kosten 0200000000000000000000000000000
Bedrijfskosten 143141122112112111108102.97895.74185.18573.23287.59785.59782.20861.49962.97847.12530.1527.27724.99930.9120.52315.04616.43617.14914.58114.59423.2979.6647.3
Bedrijfsresultaat -106-16-91-80-83-86-74-69.397-68.982-67.18281.267-78.136-76.136-72.747-52.0121.552-45.375-28.4-17.527-23.249-29.16-18.773-13.484-12.145-15.899-13.331-13.344-23.134-9.664-7.3
Bedrijfsresultaat ratio -2.718-0.11-2.935-2.5-2.862-3.44-214.493-2.067-2.578-3.7310.793-8.259-8.047-7.689-5.4820.024-25.929-16.229-1.798-13.285-16.663-10.727-8.633-2.83-12.719-10.665-10.675-141.92600
Totaal overige inkomsten en kosten netto 13-2011119874.4782.350.191-0.260.1610.1660.1540.1590.270.3010.6470.929-0.357-0.412-0.431-0.3231.3332.3660.3770.1340.0120.1140.1
Inkomen voor belasting -93-4-80-69-74-78-67-64.919-66.632-66.989281.183-77.975-75.97-72.593-51.8531.822-45.074-27.753-16.598-22.352-28.09-17.67-12.295-10.812-13.533-12.954-13.21-23.122-9.55-7.2
Inkomen voor belasting ratio -2.385-0.028-2.581-2.156-2.552-3.12-194.203-1.933-2.49-3.7210.793-8.242-8.03-7.673-5.4660.028-25.757-15.859-1.702-12.773-16.051-10.097-7.871-2.52-10.826-10.363-10.568-141.85300
Belastingkosten 011212-0.004-4.478-2.351.0041.815-0.1-0.10.438-1.82-0.258-0.131-0.482-0.856-1.254-1.482-1.534-2.4590000000
Nettowinst -93-4-81-71-75-80-66.996-60.441-64.282-67.993279.368-77.975-75.97-72.593-51.8531.822-45.074-27.753-16.598-22.352-28.09-17.67-12.295-10.812-13.533-12.954-13.21-23.122-9.55-7.2
Nettowinstmarge -2.385-0.028-2.613-2.219-2.586-3.2-194.191-1.8-2.402-3.7760.788-8.242-8.03-7.673-5.4660.028-25.757-15.859-1.702-12.773-16.051-10.097-7.871-2.52-10.826-10.363-10.568-141.85300
WPA (Winst Per Aandeel) -1.02-0.046-1.08-0.95-1.02-1.1-0.92-0.84-0.9-0.963.97-1.11-1.09-1.08-0.820.03-0.93-0.63-0.38-0.51-0.64-0.41-0.28-0.25-0.32-1.37-0.54-0.94-0.39-0.29
Verwaterde WPA -1.02-0.046-1.08-0.95-1.02-1.1-0.92-0.84-0.9-0.963.71-1.11-1.09-1.08-0.820.03-0.93-0.63-0.38-0.51-0.64-0.41-0.28-0.25-0.32-1.37-0.54-0.94-0.39-0.29
EBITDA -10420-77-68-74-77-66-62.824-64.616-65.141281.443-76.589-74.737-71.409-52.0122.294-44.719-28.04-17.527-22.363-28.277-17.82-13.484-11.171-14.984-12.503-12.578-22.402-9.036-6.814
EBITDA ratio -2.6670.138-2.484-2.125-2.552-3.08-191.304-1.871-2.415-3.6180.794-8.095-7.899-7.548-5.4820.036-25.554-16.023-1.798-12.779-16.158-10.183-8.633-2.603-11.987-10.002-10.062-137.43600